Surgery Doctors in North Haven, CT Accepting Medicare
4 Surgery doctors found. Showing 1 - 4
 Dr. Brian W Coyle, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 280 State St, North Haven, CT 06473 Phone: 203-288-2886 |
Dr. Antoine M Ferneini, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 280 State St, North Haven, CT 06473 Phone: 203-288-2886 Fax: 203-288-2576 |
Dr. Ralph Wayne Denatale, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 280 State St, North Haven, CT 06473 Phone: 203-288-2886 Fax: 203-288-2576 |
Dr. Ross David Segan, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 60 Middletown Ave, Covidien Surgical Devices - Medical Affairs, North Haven, CT 06473 Phone: 203-492-7250 |
News Archive
National quality performance standards for disposable adult absorbent products from NAFC
A council headed by the National Association For Continence (NAFC) released its recommended national quality performance standards for disposable adult absorbent products for incontinence in the frail, elderly and/or disabled populations.
Study provides possible therapeutic strategy for Alzheimer's disease via progesterone
Steroid hormones and their metabolites within the central nervous system are commonly defined as neuroactive steroids or neurosteroids. Although neuroactive steroids have been shown to improve learning and memory ability and protect against amyloid beta peptide-induced neurotoxicity, changes in their level during Alzheimer's disease and their role in Aβ-mediated cognitive impairment remain elusive given the limitation in sample sizes and analysis methods.
Helping eating for kids
Two years ago, Jenny O'Dea set herself a tough challenge: to persuade her one-year old daughter, Katherine, to eat a salty, black olive. The little girl took a small bite, Jenny and her husband cheered and applauded loudly, and Katherine grinned and ate the whole thing.
BIOTRONIK begins comparative study of ORSIRO stent with Abbott's XIENCE PRIME stent
BIOTRONIK announced today the start of an international study comparing the company's ORSIRO sirolimus-eluting coronary stent with Abbott Laboratory's XIENCE PRIME everolimus-eluting coronary stent. The first implantations in the study, called BIOFLOW-II, took place in Europe last week.
› Verified 3 days ago
Internal Medicine
Psychiatry & Neurology
Pediatrics
Cardiovascular Disease
Rheumatology
Surgery
Otolaryngology
Allergy & Immunology
Gastroenterology